After surviving both a brain tumor and pancreatic cancer, Menounos is on a mission to change how people think about early detection.

Pancreatic cancer is mostly pancreatic ductal adenocarcinoma, with late-stage detection due to non-specific symptoms like jaundice and abdominal pain. Diagnosis involves imaging tests, biopsies, and ...

Orano Med’s AlphaMedix met phase 2 endpoints with meaningful responses and manageable safety in PRRT-naïve and PRRT-exposed GEP-NETs; FDA Breakthrough designated.

Orano Med’s AlphaMedix™ hits all efficacy endpoints in a pivotal phase 2 trial for GEP-NETs, showing strong results for both PRRT-naïve and treated patients.

Google DeepMind's artificial intelligence has discovered a new way to fight cancer. The AI model, Cell2Sentence-Scale 27B, ...

The gastrointestinal neuroendocrine tumors market is experiencing steady growth driven by increasing disease prevalence, improved diagnostic capabilities, and rising awareness of targeted therapies.